SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549

                                   FORM 10-QSB

            QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (D) OF THE

                         SECURITIES EXCHANGE ACT OF 1934

                  FOR THE QUARTERLY PERIOD ENDED JUNE 30, 2002

                            Commission File #0-30503

                      CONSOLIDATED MEDICAL MANAGEMENT, INC.
             (Exact name of registrant as specified in its charter)

                                     MONTANA
         (State or other jurisdiction of incorporation or organization)

                                   82-0369233
                      (IRS Employer Identification Number)

                7500 San Felipe, Suite 600, Houston, Texas 77063
               (Address of principal executive offices )(Zip Code)

                                  713-914-8138
                (Registrant's telephone no., including area code)

Consolidated Medical Management, Inc., 5161 San Felipe, Suite 320 Houston, Texas
                                     77056,
   (Former name, former address and former fiscal year, if changed since last
                                     report)

Indicate by check mark whether the registrant (1) has filed all reports required
to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during
the  preceding  12  months  (or  for such shorter period that the registrant was
required  to  file  such  reports),  and  (2)  has  been  subject to such filing
requirements  for  the  past  90  days.
Yes  [X]  No  [ ]

The  number  of  shares outstanding of the Company's common stock as of June 30,
2002  is  shown  below:

Title  of  Class                                    Number of Shares Outstanding
Common Stock, par value $.001 per share              21,022,293

                   Documents Incorporated by Reference:  None


8/14/2002                         CMMI 2002 10-QSB                        Page 1
<PAGE>
                      CONSOLIDATED MEDICAL MANAGEMENT, INC.

                                   FORM 10-QSB

                                Table of Contents

PART  I - FINANCIAL  INFORMATION

Item 1 - Financial Statements

Item 2 - Management's Discussion and Analysis of Financial Condition and Results
         of Operations


SIGNATURES



8/14/2002                         CMMI 2002 10-QSB                       Page 2
<PAGE>
PART  I  -  FINANCIAL  INFORMATION
----------------------------------

                          ITEM 1.  FINANCIAL STATEMENTS
As  used  herein,  the  term "Company" refers to Consolidated Medical Management
Inc.  Inc.  unless otherwise indicated. Consolidated unaudited interim financial
statements  including  a  balance  sheet for the Company as of the quarter ended
June  30,  2002,  statement  of  operations, and statement of cash flows for the
interim period up to the date of such balance sheet and the comparable period of
the preceding year are attached as Pages 3 through 5 and are incorporated herein
by  this  reference.



                 [THIS SPACE HAS BEEN LEFT BLANK INTENTIONALLY]



8/14/2002                         CMMI 2002 10-QSB                        Page 3
<PAGE>
<TABLE>
<CAPTION>
                               CONSOLIDATED MEDICAL MANAGEMENT, INC.
                                     (A MONTANA CORPORATION)
                                   CONSOLIDATED BALANCE SHEET
                                          (UNAUDITED)

                                            ASSETS
                                            ------

                                                              JUNE 30, 2002    DECEMBER 31, 2001
                                                             ---------------  -------------------
<S>                                                          <C>              <C>
Current Asset
-------------
  Cash                                                                        $            5,470
  Notes Receivable - Options                                        554,839              396,003
                                                             ---------------  -------------------
                      Total Current Assets                          554,839              401,473

                                                             ---------------  -------------------
                      Total Assets                           $      554,839   $          401,473
                                                             ===============  ===================

                      LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)
                      ----------------------------------------------

Current Liabilities
-------------------
  Cash Overdraft                                             $          506   $                -
  Notes Payable-Current Portion                                      33,367               25,767
  Accounts Payable                                                  113,024              108,012
  Accrued Expenses                                                  221,301              196,630
  Convertible Debentures                                            465,000              465,000
                and Notes Payable-Current Portion
                                                             ---------------  -------------------
                      Total Current Liabilities                     833,198              795,409


  Notes Payable - Long Term Portion                                  56,867               54,726
                    Long-Term Portion
                                                             ---------------  -------------------
                      Total Long-Term Liabilities                    56,867               54,726
                                                             ---------------  -------------------
                      Total Liabilities                      $      890,065   $          850,135
                                                             ===============  ===================

Commitments and Contingencies:
------------------------------

Stockholders' Equity
--------------------
  Common Stock                                               $       15,187   $           13,591
                    $0.001  par value, 50,000,000 shares
                    authorized 15,187,347  shares  issued
                    and outstanding as of  June 30, 2002
                    and  13,587,293  shares  issued  and
                    outstanding as of December  31, 2001.
  Additional Paid-in-Capital                                      3,918,013            3,553,061
  Retained Earnings (Deficit)                                    (4,268,426)          (4,015,314)
                                                             ---------------  -------------------
                             Total Stockholders' Equity
                             (Deficit)                             (335,226)            (448,662)
                                                             ---------------  -------------------
                             Total Liabilities and
                             Stockholders' Equity (Deficit)  $      554,839   $          401,473
                                                             ===============  ===================
</TABLE>


8/14/2002                         CMMI 2002 10-QSB                        Page 4
<PAGE>
<TABLE>
<CAPTION>
                                CONSOLIDATED MEDICAL MANAGEMENT, INC.
                                        (A MONTANA CORPORATION)
                                 CONSOLIDATED STATEMENT OF OPERATIONS
                                              (UNAUDITED)


                                       THREE MONTHS ENDED JUNE 30,        SIX MONTHS ENDED JUNE 30,
                                    ---------------------------------  -------------------------------
                                          2002              2001            2002             2001
                                    -----------------  --------------  ---------------  --------------
<S>                                 <C>                <C>             <C>              <C>
Revenues                            $              -   $           -   $            -   $           -
--------

Operating Expenses
  Personnel Costs                              9,173               -           52,736               -
  Consulting                                   8,000               -          154,000               -
  Legal and Professional                                       2,800           10,296          18,800
  Office Expense                               2,507             913           11,409           2,342
  Occupancy                                                        -                -           1,880
                                    -----------------  --------------  ---------------  --------------
  Total Operating Expenses          $         19,680   $       3,713   $      228,441   $      23,022

Income (Loss) from Operations                (19,680)         (3,713)        (228,441)        (23,022)

Other Income (Expenses)
  Other                                            -               -                          528,387
  Interest Expense                           (13,046)        (20,261)         (24,671)        (41,251)
  Interest Income                                  -               -                                -
                                    -----------------  --------------  ---------------  --------------
                                             (13,046)        (20,261)         (24,671)        487,136

Income (Loss) before Income Taxes   $        (32,726)  $     (23,974)  $     (253,112)  $     464,114

Income Tax Expense                                 -               -                -               -
                                    -----------------  --------------  ---------------  --------------

Net Income (Loss)                   $        (32,726)  $     (23,974)  $     (253,112)  $     464,114
                                    =================  ==============  ===============  ==============

Net Income (Loss) per Share         $         (0.002)  $      (0.009)         (0.0169)  $      (0.019)
                                    =================  ==============  ===============  ==============
</TABLE>


8/14/2002                         CMMI 2002 10-QSB                        Page 5
<PAGE>
<TABLE>
<CAPTION>
                                 CONSOLIDATED MEDICAL MANAGEMENT, INC.
                                 CONSOLIDATED STATEMENT OF CASH FLOWS
                                              (UNAUDITED)

                                                                          SIX MONTHS ENDED JUNE 30,
                                                                       -------------------------------
                                                                            2002            2001
                                                                       --------------  ---------------
<S>                                                                    <C>             <C>
Cash Flows from Operating Activities:
-------------------------------------
  Net Income (Loss)                                                    $    (253,112)  $      464,114
  Adjustments to Reconcile Net Income (Loss) to Net Cash Provided by
    Operating Activities:
      Depreciation and Amortization                                                -                -
      Non Cash Consulting and Services Paid by Stock Issue                         -                -
      (Increase) Decrease in Receivables                                    (158,836)               -
      (Increase) Decrease in Accounts Payable                                  5,012         (120,986)
      (Increase) Decrease in Interest Payable                                      -           40,294
      (Increase) Decrease in Accrued Expenses                                 24,671                -
                                                                       --------------  ---------------
           Net Cash Provided (Used) by Operating Activities            $    (382,265)  $      383,422
                                                                       --------------  ---------------

Cash Flows from Investing Activities:
-------------------------------------

  Assets Disposed                                                                  -           17,415
                                                                                   -                -
                                                                       --------------  ---------------
           Net Cash Provided (Used) by Investing Activities            $           -   $       17,415
                                                                       --------------  ---------------


Cash Flows from Financing Activities:
-------------------------------------

  Increase in Short-Term Debt                                                  9,741            1,880
  Increase in Paid  in capital                                               364,952
  Common Stock                                                                 1,596         (404,000)
                                                                       --------------  ---------------
           Net Cash Provided (Used) by Financing Activities            $     376,289   $     (402,120)
                                                                       --------------  ---------------
Net Increase (Decrease) in Cash                                        $      (5,976)  $       (1,283)

Cash, Beginning of period                                                      5,470            1,724
                                                                       --------------  ---------------
Cash, End of period                                                    $        (506)  $          441
                                                                       ==============  ===============

Supplemental Disclosure of Cash Flow Information
  Cash Paid During the Period for:
    Interest                                                           $           -   $            -
                                                                       ==============  ===============
    Income Taxes                                                       $           -   $            -
                                                                       ==============  ===============
</TABLE>


8/14/2002                         CMMI 2002 10-QSB                        Page 6
<PAGE>
                      Consolidated Medical Management, Inc.
                          Notes to Financial Statements


NOTE  1-  BASIS  OF  PRESENTATION
---------------------------------

GENERAL
-------
The  consolidated  unaudited  interim  financial statements of the Company as of
June  30,  2002  and  for the three and six months ended June 30, 2002, included
herein  have  been  prepared  in accordance with the instructions for Form 10QSB
under  the  Securities  Exchange  Act  of  1934,  as  amended, and Article 10 of
Regulation  S-X  under  the Securities Act of 1933, as amended. The December 31,
2001  Consolidated  Balance Sheet was derived from audited financial statements,
but  does  not include all disclosures required by generally accepted accounting
principles.  Certain  information  and  note  disclosures  normally  included in
financial  statements  prepared in accordance with generally accepted accounting
principles have been condensed or omitted pursuant to such rules and regulations
relating  to  interim  consolidated  financial  statements.

In  the  opinion  of management, the accompanying consolidated unaudited interim
financial  statements  reflect  all  adjustments,  consisting  only  of  normal
recurring adjustments, necessary to present fairly the financial position of the
Company  at June 30, 2002, and the results of their operations for the three and
six  months ended June 30, 2002 and 2001, and their cash flows for the three and
six  months  ended  June  30,  2002  and  2001.

The  results  of  operations  for such periods are not necessarily indicative of
results  expected  for  the  full year or for any future period. These financial
statements should be read in conjunction with the audited consolidated financial
statements  as  of  December 31, 2001and related notes included in the Company's
Form  10-KSB  filed  with  the  Securities  and  Exchange  Commission

                                  Organization

The  Company  was  incorporated under the laws of the State of Montana on August
13,  1981.  The  Company  ceased its mining operations in 1985, and discontinued
all  business  operations  in  1990.  In  August of 2001, the Company decided to
refocus  on  the oil and gas industry and entered into several Letters of Intent
only  one  of  which  survived  the  due  diligence  process.


8/14/2002                         CMMI 2002 10-QSB                        Page 7
<PAGE>
                      Consolidated Medical Management, Inc.
                          Notes to Financial Statements


NOTE  2  -  SUMMARY  OF  SIGNIFICANT  ACCOUNTING  POLICIES
----------------------------------------------------------
ACCOUNTING  METHOD
------------------
Accounting  policies of the Company conform to the generally accepted accounting
principles  and  reflect  practices  appropriate  to  the  industry  in which it
operates.  The  significant  policies  are  summarized  below.

     -    RECEIVABLES

     The  Company,  through an S-8 offering, grants options and stock to several
     individuals for stock. As of June 30, 2002 and December 31, 2001, there was
     $  396,003 and $554,839 owed to the Company for stock purchased through the
     S-8  stock  program.

     -    PROPERTY,  EQUIPMENT  AND  DEPRECIATION

     Expenditures  for  property,  plant  and  equipment  are  recorded at cost.
     Renewals  and  improvements, which extend the economic life of such assets,
     are  capitalized.  Expenditures for maintenance, repairs and other renewals
     are  charged  to  expense. For major dispositions, the cost and accumulated
     depreciation are removed from the accounts and any gain or loss is included
     in  the  results of operations. During the year 2001, the Company abandoned
     the remaining assets relating to the healthcare operations in the amount of
     $17,415.

     -    CASH  FLOWS  AND  CONCENTRATION  OF  CREDIT  RISK

     Cash  consists  principally  of  demand deposits at commercial banks. These
     balances,  as  reflected  in the bank's records, are insured by the Federal
     Deposit Insurance Corporation up to $100,000. At December 31, 2001 and June
     30,  2002,  the  Company's  deposits  did  not  exceed  the insured limits.

     During  2000,  the  Company  adopted  the  U.S.  Securities  and  Exchange
     Commission's  ("SEC")  Staff Accounting Bulletin 101, "Revenue Recognition"
     ("SAB  101"), which provides guidance on the recognition, presentation, and
     disclosure  of  revenue  in  financial  statements  filed with the SEC. The
     adoption  of  SAB  101  did  not  have  a  material effect on the Company's
     business,  financial  condition,  results  of operations or cash flows. The
     Company  believes  that  SAB  101  has  been followed in the recognition of
     revenues.

EARNINGS  PER  COMMON  SHARE
----------------------------
The  Company adopted Financial Accounting Standards  (SFAS) No.  128,  "Earnings
Per Share," which simplifies the computation of earnings per share requiring the
restatement  of  all  prior  periods.

Basic  earnings  per  share  are  computed  on the basis of the weighted average
number  of  common  shares  outstanding  during  each  year.

Diluted  earnings  per  share  are computed on the basis of the weighted average
number  of  common  shares  and  dilutive  securities  outstanding.  Dilutive
securities  having  an  anti-dilutive  effect  on diluted earnings per share are
excluded  from  the  calculation.  The  Company  does  not  have  any  dilutive
securities  as  of  June  30,  2002.


8/14/2002                         CMMI 2002 10-QSB                        Page 8
<PAGE>
                   Consolidated Medical Management Inc., Inc.
                          Notes to Financial Statements


NOTE  3  -  CONVERTIBLE  DEBENTURES  AND  NOTES  PAYABLE
--------------------------------------------------------

The  Company issued convertible debentures in 1998 that are subordinated to bank
debt and secured leases.  The debentures are otherwise unsecured but are given a
preference over unsecured debt. The debentures include interest at fifteen (15%)
percent,  interest  is  payable  in  monthly installments.  Each debenture has a
conversion right for each holder to convert the debenture principal to shares of
the  Company's  common  stock  at the greater of $2.50 per share or ninety (90%)
percent  of  the  bid  price,  whichever  is  greater on the date of conversion.
Accrued  interest and any principal amount not converted to shares of stock will
be  paid  in  cash  at conversion.  The debentures are due one year from date of
issue.  All  debentures issued in 1998 were due in 1999, and they are in default
as  of  June  30,  2002.

The  Company issued convertible promissory notes payable in 1998.  The notes are
unsecured  and  include  interest  at  ten (10%) percent, interest is payable in
monthly  installments.  Each  note  has  a  conversion  right for each holder to
convert  the  note's  unpaid  principal  to shares of the Company's common stock
based  on $2.50 per share, or a total of 90,000 at the note holder's discretion.
Accrued  interest and any principal amount not converted to shares of stock will
be  paid  in  cash  at conversion. As of December 31, the company had issued and
outstanding  $325,000 in debentures.  The notes were due July 31, 1999, and they
are  in  default  as  of  June  30  2002.

The  Company  has  entered  into  an  agreement  with  Spectrum  Financial, Inc.
("Spectrum")  whereby  Spectrum  will exchange shares it owns with the debenture
holder  upon  exercise  of the debenture's conversion option, in satisfaction of
the  Company's  obligations  under  the  conversion  provisions.  In  exchange,
Spectrum  will then receive an unsecured note payable from the Company (see Note
7)  for  the  face  amount  of the debenture surrendered.  During the year ended
December  31,  1998,  Spectrum  exchanged  a  total  of  14,000 of its shares in
connection  with this agreement and received five notes payable from the Company
totaling  $35,000.

     Total  Convertible  Debentures  and  Notes Payable          $      465,000
     Less: Current Portion                                             (465,000)
                                                                 ---------------
     Long-Term  Portion                                          $            0
                                                                 ===============

NOTE  4  -  COMMON  AND  PREFERRED  STOCK
-----------------------------------------

COMMON  STOCK
-------------

The  Company's  common  stock  is  $0.001 par value, there are 50,000,000 shares
authorized  as  of  as  of  December 31, 2001 and June 30, 2002, the Company had
13,587,293  and  15,187,293  shares  issued  and  outstanding,  respectively.

PREFERRED  STOCK
----------------

In  1998,  the Company amended its articles to authorize Preferred Stock.  There
are  20,000,000  shares  authorized with a par value of $ 0.001.  The shares are
non-voting  and  non-redeemable  by the Company.  The Company further designated
two  series  of  its  Preferred Stock:  "Series 'A' $12.50 Preferred Stock" with
2,159,193  shares of the total shares authorized and "Series 'A' $8.00 Preferred
Stock,"  with  the  number  of authorized shares set at 1,079,957 shares.  As of
June  30, 2002 and December 31, 2001 there are no shares issued and outstanding.


8/14/2002                         CMMI 2002 10-QSB                        Page 9
<PAGE>
                      Consolidated Mineral Management, Inc.
                          Notes to Financial Statements


NOTE  4  -  COMMON  AND  PREFERRED  STOCK  (CONTINUATION)
---------------------------------------------------------
DIVIDENDS
---------

Dividends are non-cumulative, however, the holders of such series, in preference
to  the  holders  of any common stock, shall be entitled to receive, as and when
declared  payable by the Board of Directors from funds legally available for the
payment  thereof,  dividends  in lawful money of the United States of America at
the  rate  per annum fixed and determined as herein authorized for the shares of
such  series,  but  no  more, payable quarterly on the last days of March, June,
September, and December in each year with respect to the quarterly period ending
on  the  day  prior to each such  respective dividend payment date.  In no event
shall  the  holders of either series receive dividends of more than percent (1%)
in  any  fiscal  year.  Each share of both series shall rank on parity with each
other  share  of  preferred  stock,  irrespective  of  series,  with  respect to
dividends  at  the  respective  fixed  or  maximum  rates  for  such  series.

CONVERSION  PROVISIONS
----------------------

Any holder of either series may convert any or all of such shares into shares of
common  stock  of the Company at any time. Said shares shall be convertible at a
rate  equal  to three (3) shares of common stock of the Company for each one (1)
share of Series "A" of $ 12.50 Preferred Stock.  The Series "A" $12.50 Preferred
Stock  shall  be  convertible, in whole or in part, at any time after the common
stock  of  the Company shall maintain an average bid price per share of at least
$12.50  for  ten  (10)  consecutive  trading  days.

Series  "A"  $8.00 Preferred Stock shall be convertible at a rate equal to three
(3)  shares  of common stock of the Company for each one (1) share of Series "A"
$8.00  Preferred  Stock.  The  Series  "A"  $8.00  Preferred  Stock  shall  be
convertible,  in  whole  or  in  part, at any time after the common stock of the
Company  shall maintain an average bid price per share of at least $8.00 for ten
(10)  consecutive  trading  days.

The  preferential  amount  payable  with  respect  to shares of either Series of
Preferred  Stock  in  the  event  of  voluntary  or  involuntary  liquidation,
dissolution,  or  winding-up, shall be an amount equal to $5.00 per share,  plus
the  amount  of  any  dividends  declared  and  unpaid  thereon.

NOTE  5  -  COMMITMENT  AND  CONTINGENCIES

The Company has not recognized any commitments or contingencies at this time.

The  Company's  financial  statements  are  prepared  using  generally  accepted
accounting  principles  applicable  to  a  going concern, which contemplates the
realization  of  assets  and  liquidation of liabilities in the normal course of
business.  However, the Company does not have significant cash or other material
assets,  nor  does it have an established source of revenues sufficient to cover
its  operating costs that raises substantial doubt about its ability to continue
as a going concern. The stockholders/officers and or directors have committed to
advancing  operating  costs  of  the  Company  interest  free


Item  2. Management's Discussion and Analysis of Financial Condition and Results
of  Operations.

The  following  discussion  should  be  read  in  conjunction with our unaudited
consolidated  interim financial statements and related notes thereto included in
this  quarterly  report and in our audited consolidated financial statements and
Management's  Discussion  and  Analysis  of  Financial  Condition and Results of
Operations ("MD&A") contained in our Form 10-KSB for the year ended December 31,
2001.  Certain  statements in the following MD&A are forward looking statements.
Words  such as "expects", "anticipates", "estimates" and similar expressions are
intended  to identify forward looking statements. Such statements are subject to
risks  and  uncertainties  that  could cause actual results to differ materially
from  those  projected.


8/14/2002                         CMMI 2002 10-QSB                       Page 10
<PAGE>
RESULTS  OF OPERATIONS FOR THE THREE MONTHS ENDED MARCH 31, 2002 COMPARED TO THE
--------------------------------------------------------------------------------
THREE  MONTHS  ENDED  MARCH  31,  2001
--------------------------------------

For  the  quarter ended June 30, 2002, our net loss was $(32,726) as compared to
$(23,974)  for  the  quarter ended June 30, 2001. CMMI is still in a development
stage and will continue to incur costs as the Company evaluates energy prospects
prior  to  investing  in  them.  The  Company has relied on key stockholders and
officers  to bear the substantial costs that are involved in positioning CMMI to
commence  commercial  operations. We expect to continue to incur losses and face
cash  flow  problems  for  a  period  that  could  extend  for  several  years.
We  believe  that we will need to raise cash of at least $20,000 to continue our
operations  through  the  end  of  2002.  The  Company was successful in raising
$30,000  in  the  third  quarter  of  2002  through private placements; however,
additional  capital  will  be  required  for the company to continue operations.

We  believe  that we will need to raise cash of at least $20,000 to continue our
operations  through  the  end  of  2002.  The  Company was successful in raising
$30,000  in  the  third  quarter  of  2002  through private placements; however,
additional  capital  will  be  required  for the company to continue operations.

LIQUIDITY  AND  CAPITAL  RESOURCES
----------------------------------

During  the  year  ended  December  31,  2001, we experienced negative financial
results  that  have  continued  during  the  three months ended June 30, 2002 as
follows:

                                       THREE  MONTHS       YEAR
                                           ENDED           ENDED
                                         JUNE  31,      DECEMBER 31,
                                           2002             2001
                                      --------------   --------------
Net  loss                              $  (32,726)     $  (167,551)*

Negative  working  capital               (833,198)        (795,409)

Accumulated  deficit                   (4,268,426)       (4,015,314)


*  The net loss for the three months ended June 31, 2001 was 23,794

In  addition  to  its  negative  financial  results, we have significant accrued
liabilities,  accounts  payable and obligation to stockholders for expenses that
they  have  paid  on  behalf  of  our  Company.

As  a development stage company, CMMI has not generated any revenue and has been
dependent  on  debt  and  equity raised from individual investors to sustain its
operations.  During the three months ended June 30, 2002, the Company incurred a
net loss of $(32,726) compared to net loss of $23,794 for the three months ended
June  30,  2001.  At  June  30, 2002 the Company had negative working capital of
$(833,198). These factors raise substantial doubt about the Company's ability to
continue  as  a  going  concern.

The  Company entered into private placement transactions in the third quarter of
2002  and raised $30,000.  The Company is currently considering a public sale or
private  placement  of  its  common  stock  if  an active trading market for its
existing  outstanding  shares  can  be established. The Company is attempting to
finalize an energy acquisition which would be revenue producing.


8/14/2002                         CMMI 2002 10-QSB                       Page 11
<PAGE>
The  Company  is  in  discussions  to  raise the required funding. However, such
sources  of  funding  may be unavailable. The Company's long-term viability as a
going  concern  is  dependent  on  certain  key  factors  as  follows:

     -    The  Company's  ability  to  obtain  adequate  sources  of  funding to
          continue  the  implementation  of  its  business  strategy. Sources of
          funding  may  not  be  available  on  terms that are acceptable to the
          Company  and  existing  stockholders,  or  may include terms that will
          result  in  substantial  dilution  to  existing  stockholders.

     -    The  ability  of  the  Company  to  find  suitable energy prospects to
          establish  a  revenue  base.

     -    The  ability  of  the  Company  to  ultimately  achieve  adequate
          profitability  and  strong  operating  cash  flows  to  sustain  its
          operations

     -    The  ability  to  obtain  adequate  sources of funding to continue the
          implementation  of  our  strategic  plan.

As  a  result  of  the  liquidity  issues  facing  the  Company,  the  Company's
independent  accountant  included  an  emphasis  paragraph in his report for the
quarter  ended June 30, 2002 that addresses the substantial doubt that exists as
to  the  Company's  ability  to  continue  as  a  going  concern.

The  statements  contained herein and other information contained in this report
may  be  based,  in  part,  on  management's  estimates,  projections, plans and
judgments. As such, these are forward looking statements and involve a number of
risks  and  uncertainties. A number of factors, which could cause actual results
to  differ  materially, include: general economic conditions, competitive market
influences,  technology  changes,  and  other  influences  beyond the control of
management.  This  report contains a number of forward-looking statements, which
reflect  the Company's current views with respect to future events and financial
performance  including  statements  regarding  the  Company's projections. These
forward-looking  statements  are subject to certain risks and uncertainties that
could cause actual results to differ materially from historical results or those
anticipated.  In  this  report,  the words "anticipates", "believes", "expects",
"intends",  "future",  "plans",  "targets"  and  similar  expressions  identify
forward-looking statements. Readers are cautioned to not place undue reliance on
the forward-looking statements contained herein, which speak only as of the date
hereof.  The  Company  undertakes  no  obligation  to  publicly  revise  these
forward-looking  statements,  to  reflect events or circumstances that may arise
after  the  date  hereof.  Additionally,  these  statements are based on certain
assumptions  that  may  prove  to  be erroneous and are subject to certain risks
including,  but  not  limited  to,  the  Company's  dependence  on  limited cash
resources,  and  its  dependence  on  certain  key personnel within the Company.
Accordingly,  actual  results  may  differ,  possibly  materially,  from  the
predictions  contained  herein.


                                    PART II

Pursuant  to  the  Instructions on Part II of the Form 10-QSB, Items 1, 3, and 5
are  omitted.

Item  2.  Changes  in  Securities

None

Item  4.  Submission  of  Matters  to  a  Vote  of  Security  Holders.

None

Item  6.  Exhibits  and  Reports  on  Form  8-K
     (a)  Exhibits  -  99.1,  Certification  of  Officers
     (b)  Reports  on  Form  8-K  --  None


8/14/2002                         CMMI 2002 10-QSB                       Page 12
<PAGE>
                                   SIGNATURES

Pursuant  to  the requirements of section 13 or 15(d) of the Securities Exchange
Act  of  1934,  the undersigned has duly caused this Form 10-QSB to be signed on
its  behalf  by  the  undersigned,  there  unto  duly authorized, in the City of
Houston,  Texas,  on  August  12,  2002.

CONSOLIDATED  MEDICAL  MANAGEMENT,  INC.

By:  /s/  Timothy  G.  Byrd,  Sr.




---------------------------------------------
Timothy G. Byrd, Sr. Chief Executive Officer, and Director


8/14/2002                         CMMI 2002 10-QSB                       Page 13
<PAGE>